U.S. Markets closed

Pfizer’s Valuation as of May 22

Mike Benson
Pfizer’s Valuation as of May 22

Pfizer (PFE) reported a 1% growth in revenues to $12.9 billion in the first quarter compared to $12.8 billion in the first quarter of 2017. It surpassed Wall Street analysts’ estimate for EPS but missed the revenue estimate. It reported EPS of $0.77 on revenues of $12.9 billion compared to the EPS estimate of $0.74 on revenues of $13.1 billion.